Pharmacological studies on ethyl-3,5,6-tri-O-benzyl-D-glucofuranoside (CIBA 21,401-BA).
D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002351:Carrageenan; D003436:Croton Oil; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy*; D005122:Exudates and Transudates; D005260:Female; D005547:Foreign Bodies / Q000150:complications; D005557:Formaldehyde; D006027:Glycosides / Q000627:therapeutic use*; D003368:Gossypium; D006099:Granuloma / Q000188:drug therapy* / Q000209:etiology; D006854:Hydrocortisone / Q000627:therapeutic use; D010047:Ovalbumin; D010653:Phenylbutazone / Q000627:therapeutic use; D051381:Rats
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D006027:Glycosides; D005557:Formaldehyde; D003436:Croton Oil; D002351:Carrageenan; D010047:Ovalbumin; D010653:Phenylbutazone; D006854:Hydrocortisone